CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Activity
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

1 hedge funds and large institutions have $1.85K invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-11
Holders Change %
-91.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Focus Partners Wealth
Focus Partners Wealth
Massachusetts
-$348K
2
Jane Street
Jane Street
New York
-$346K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$271K
4
UBS Group
UBS Group
Switzerland
-$29.7K
5
Morgan Stanley
Morgan Stanley
New York
-$13.7K
Name Holding Trade Value Shares
Change 		Shares
Change %
Osaic Holdings
1
Osaic Holdings
Arizona
$1.85K -$7.59K -617 -80%
Focus Partners Wealth
2
Focus Partners Wealth
Massachusetts
– -$348K -36,879 Closed
Jane Street
3
Jane Street
New York
– -$346K -36,741 Closed
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
– -$271K -28,710 Closed
UBS Group
5
UBS Group
Switzerland
– -$29.7K -3,147 Closed
Morgan Stanley
6
Morgan Stanley
New York
– -$13.7K -1,448 Closed
BBPWM
7
Blue Bell Private Wealth Management
Pennsylvania
– -$6.82K -723 Closed
NFSG
8
Newbridge Financial Services Group
Florida
– -$2.83K -300 Closed
Wells Fargo
9
Wells Fargo
California
– -$2.36K -250 Closed
NA
10
NewEdge Advisors
Louisiana
– -$1.42K -150 Closed
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
– -$1K -82 Closed
DF
12
Dunhill Financial
United Kingdom
– -$2.41K -62 Closed